Jan 06, 2020
Eiger Updates on 2019 Progress and 2020 Milestones Expected
Dec 17, 2019
First-Ever Treatment for Rare, Rapid-Aging Disease Progeria Submitted in New Drug Application to the FDA
Dec 16, 2019
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
Dec 09, 2019
InMed Receives Clinical Trial Application Approval for INM-755, a Rare Cannabinoid Formulation Under Development for the Treatment of Epidermolysis Bullosa
Dec 04, 2019
FDA Grants Orphan Drug Designation to APR Applied Pharma Research's Investigational Drug for the Treatment of Epidermolysis Bullosa
Nov 18, 2019
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO
Nov 05, 2019
InMed Submits Clinical Trial Application to Evaluate INM-755 in Phase 1 Trial
Oct 31, 2019
2019 Research Grant Recipients Announced by the VHL Alliance
Oct 03, 2019
Global Prader-Willi Syndrome (PWS) Therapeutics Markets, 2017-2018 & 2019-2024: Expected Launch of Novel Therapies to Fuel Market Growth
Aug 08, 2019
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 08, 2019
Butterfly Children: Epidermolysis Bullosa and Anesthesia
Jul 29, 2019
RegeneRx's RGN-137 for Epidermolysis Bullosa Subject of New Article in Seeking Alpha Investor Site
Jul 03, 2019
Rongxiang Xu Regenerative Life Non-Profit Fund Joined the Rare Disease Care Movement of Chinese Red Cross Foundation -- Launched "Butterfly Baby Rescue Plan"
Jun 10, 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
May 20, 2019
Aegle Therapeutics Corp. Receives IND Clearance from FDA for Its MSC-Derived Extracellular Vesicle Therapy for Dystrophic Epidermolysis Bullosa
May 17, 2019
Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer
May 17, 2019
Countries Around the World to Shine a Light on NF on May 17, World NF Awareness Day
May 09, 2019
Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update
Apr 30, 2019
Phoenix Tissue Repair Receives FDA Fast Track Designation for PTR-01 for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) and Provides Updates on the Phase 1/2 Clinical Study
Apr 30, 2019
TSC Global Awareness Day Scheduled for May 15